Original Research

Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with operable breast cancer

Zhang MM, Wei W, Liu JL, Yang HW, Jiang Y, Tang W, Li QY, Liao XM

OncoTargets and Therapy 2016, 9:3443-3450

Published Date: 8 June 2016